These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 12046687)
1. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters? Kovacs E; Kuehn JJ Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687 [TBL] [Abstract][Full Text] [Related]
2. Effects of Viscum album extract therapy in patients with cancer: relation with interleukin-6, soluble interleukin-6 receptor, and soluble gp130. Kovacs E J Altern Complement Med; 2004 Apr; 10(2):241-6. PubMed ID: 15165404 [TBL] [Abstract][Full Text] [Related]
3. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission. Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616 [TBL] [Abstract][Full Text] [Related]
4. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125 [TBL] [Abstract][Full Text] [Related]
5. Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients. Kovacs E Biomed Pharmacother; 2001 Sep; 55(7):391-6. PubMed ID: 11669502 [TBL] [Abstract][Full Text] [Related]
6. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117 [TBL] [Abstract][Full Text] [Related]
7. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. Sherwin JR; Smith SK; Wilson A; Sharkey AM J Clin Endocrinol Metab; 2002 Aug; 87(8):3953-60. PubMed ID: 12161539 [TBL] [Abstract][Full Text] [Related]
8. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance]. Li Y; Wang Y; Qi L Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537 [TBL] [Abstract][Full Text] [Related]
9. High circulating levels of biologically inactive IL-6/SIL-6 receptor complexes in systemic juvenile idiopathic arthritis: evidence for serum factors interfering with the binding to gp130. Pignatti P; Ciapponi L; Galle P; Hansen MB; Massa M; Meazza C; Paonessa G; Novick D; Ciliberto G; Martini A; De Benedetti F Clin Exp Immunol; 2003 Feb; 131(2):355-63. PubMed ID: 12562400 [TBL] [Abstract][Full Text] [Related]
10. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling. Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558 [TBL] [Abstract][Full Text] [Related]
11. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa. Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226 [TBL] [Abstract][Full Text] [Related]
12. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis. Padberg F; Feneberg W; Schmidt S; Schwarz MJ; Körschenhausen D; Greenberg BD; Nolde T; Müller N; Trapmann H; König N; Möller HJ; Hampel H J Neuroimmunol; 1999 Oct; 99(2):218-23. PubMed ID: 10505978 [TBL] [Abstract][Full Text] [Related]
13. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes. Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452 [TBL] [Abstract][Full Text] [Related]
14. Profile of soluble cytokine receptors in Crohn's disease. Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma. Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333 [TBL] [Abstract][Full Text] [Related]
16. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex. Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 receptor signaling. I. gp80 and gp130 receptor interaction in the absence of interleukin-6. Gaillard JP; Mani JC; Liautard J; Klein B; Brochier J Eur Cytokine Netw; 1999 Mar; 10(1):43-8. PubMed ID: 10210772 [TBL] [Abstract][Full Text] [Related]
18. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth. Murakami-Mori K; Taga T; Kishimoto T; Nakamura S Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639 [TBL] [Abstract][Full Text] [Related]
19. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130. Yasukawa K; Futatsugi K; Saito T; Yawata H; Narazaki M; Suzuki H; Taga T; Kishimoto T Immunol Lett; 1992 Feb; 31(2):123-30. PubMed ID: 1740350 [TBL] [Abstract][Full Text] [Related]
20. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]